HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vincenzo Pezzi Selected Research

Adrenal Cortex Neoplasms (Adrenocortical Cancer)

1/2021SIRT1 is involved in adrenocortical cancer growth and motility.
2/2020Functional Albumin Nanoformulations to Fight Adrenocortical Carcinoma: a Redox-Responsive Approach.
1/2020Statins Reduce Intratumor Cholesterol Affecting Adrenocortical Cancer Growth.
12/2017GPER-independent inhibition of adrenocortical cancer growth by G-1 involves ROS/Egr-1/BAX pathway.
11/2017Role of Scaffold Protein Proline-, Glutamic Acid-, and Leucine-Rich Protein 1 (PELP1) in the Modulation of Adrenocortical Cancer Cell Growth.
9/2015Estrogen related receptor α (ERRα) a promising target for the therapy of adrenocortical carcinoma (ACC).
5/2015C-MYC modulation induces responsiveness to paclitaxel in adrenocortical cancer cell lines.
3/20141α,25-Dihydroxyvitamin D₃ inhibits the human H295R cell proliferation by cell cycle arrest: a model for a protective role of vitamin D receptor against adrenocortical cancer.
12/2012Targeting estrogen receptor-α reduces adrenocortical cancer (ACC) cell growth in vitro and in vivo: potential therapeutic role of selective estrogen receptor modulators (SERMs) for ACC treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vincenzo Pezzi Research Topics

Disease

40Neoplasms (Cancer)
06/2022 - 07/2002
21Breast Neoplasms (Breast Cancer)
06/2022 - 07/2002
9Adrenal Cortex Neoplasms (Adrenocortical Cancer)
01/2021 - 12/2012
7Adrenocortical Carcinoma
02/2020 - 02/2008
7Carcinogenesis
01/2020 - 05/2004
4Leydig Cell Tumor
05/2012 - 08/2007
3Testicular Neoplasms (Testicular Cancer)
01/2020 - 05/2012
2Prostatic Neoplasms (Prostate Cancer)
03/2019 - 06/2004
2Neoplasm Metastasis (Metastasis)
01/2018 - 06/2015
2Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 01/2013
2Ovarian Neoplasms (Ovarian Cancer)
05/2015 - 12/2008
2Hepatocellular Carcinoma (Hepatoma)
03/2006 - 05/2005
1Diabetic Foot
01/2022
1Ulcer
01/2022
1COVID-19
10/2021
1Virus Diseases (Viral Diseases)
10/2021
1Histiocytoma
05/2021
1Hypercholesterolemia
01/2020
1Alopecia (Baldness)
07/2018
1Triple Negative Breast Neoplasms
05/2018
1Mental Disorders (Mental Disorder)
04/2017
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2017
1Cognitive Dysfunction
04/2017
1Tics (Tic)
06/2015

Drug/Important Bio-Agent (IBA)

20Estrogens (Estrogen)FDA Link
01/2022 - 07/2002
12Estrogen ReceptorsIBA
01/2022 - 07/2002
12Aromatase (CYP19)IBA
05/2015 - 07/2002
9Hormones (Hormone)IBA
01/2022 - 07/2002
9Estrogen Receptor alphaIBA
12/2017 - 07/2002
7Estradiol (Delestrogen)FDA LinkGeneric
01/2020 - 07/2002
7Proteins (Proteins, Gene)FDA Link
11/2017 - 09/2007
7Biological ProductsIBA
04/2017 - 07/2002
6ResveratrolIBA
05/2021 - 07/2009
4CholesterolIBA
01/2020 - 01/2018
4Messenger RNA (mRNA)IBA
03/2014 - 09/2007
4Insulin-Like Growth Factor I (IGF-1)IBA
11/2012 - 09/2007
4Estrogen Receptor betaIBA
12/2008 - 06/2004
3Pharmaceutical PreparationsIBA
01/2021 - 02/2004
3GTP-Binding Proteins (G-Protein)IBA
12/2017 - 08/2013
3G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
05/2015 - 06/2004
3SteroidsIBA
09/2013 - 06/2004
2LigandsIBA
01/2022 - 01/2018
2Molecularly Imprinted PolymersIBA
10/2021 - 01/2020
2PhenolsIBA
06/2021 - 01/2013
2Mitotane (Lysodren)FDA Link
01/2021 - 01/2020
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2020 - 01/2018
2Steroid Receptors (Steroid Receptor)IBA
03/2019 - 06/2004
2Insulin-Like Growth Factor II (Somatomedin A)IBA
11/2017 - 08/2015
2Transcription Factors (Transcription Factor)IBA
09/2015 - 09/2007
2XCT790IBA
09/2015 - 06/2015
2PesticidesIBA
05/2015 - 12/2008
2AtrazineIBA
05/2015 - 12/2008
23,4-dihydroxyphenylethanol (hydroxytyrosol)IBA
03/2014 - 06/2010
2oleuropeinIBA
03/2014 - 06/2010
2PolyphenolsIBA
12/2013 - 06/2010
2Growth Factor ReceptorsIBA
09/2013 - 12/2008
2Olive OilIBA
01/2013 - 06/2010
2Stanozolol (Winstrol)FDA Link
11/2012 - 05/2012
2Nandrolone (Nortestosterone)IBA
11/2012 - 05/2012
2AndrogensIBA
06/2004 - 07/2002
1Protein Isoforms (Isoforms)IBA
01/2022
1HydrogelsIBA
01/2022
1SilverIBA
01/2022
1Carboxymethylcellulose Sodium (Polycell)FDA Link
01/2022
1PlasticsIBA
10/2021
1AntibodiesIBA
10/2021
1CurcuminIBA
10/2021
1Dinoprostone (PGE2)FDA Link
05/2021
1Cell Cycle ProteinsIBA
05/2021
1LipopolysaccharidesIBA
05/2021
1Sirtuin 1IBA
01/2021
1sirtinolIBA
01/2021
1AlbuminsIBA
02/2020
1Glutathione (Reduced Glutathione)IBA
02/2020
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2020
1Sunitinib (Sutent)FDA Link
01/2020
1Cytotoxins (Cytolysins)IBA
01/2020
1Simvastatin (Zocor)FDA LinkGeneric
01/2020
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2020
1OxysterolsIBA
01/2019
1PolymersIBA
07/2018
1Antineoplastic Agents (Antineoplastics)IBA
05/2018
1Coenzyme A (CoA)IBA
01/2018
1Leucine (L-Leucine)FDA Link
11/2017
1Glutamic Acid (Glutamate)FDA Link
11/2017
1Proline (L-Proline)FDA Link
11/2017
1ZeaxanthinsIBA
04/2017
1Carotenoids (Carotene)IBA
04/2017
1Alkenes (Olefins)IBA
01/2016
1titanoceneIBA
11/2015
1Titanocene YIBA
11/2015
1MetalsIBA
11/2015
1Cyclopentanes (Cyclopentane)IBA
11/2015
1TitaniumIBA
11/2015
1Type I DNA Topoisomerases (Topoisomerase I)IBA
11/2015
1CarbonIBA
11/2015
1ERRalpha Estrogen-Related ReceptorIBA
09/2015
1Doxycycline (Periostat)FDA LinkGeneric
06/2015

Therapy/Procedure

5Therapeutics
06/2022 - 09/2013
1Precision Medicine
01/2020